An antigen-targeted approach to adoptive transfer therapy of cancer

Cancer Research

Volumn 59, Issue 9, 1999, Pages 2167-2173

  Valmori, Danila ^a   Pittet, Mikaël J ^a   Rimoldi, Donata ^b   Liénard, Danielle ^a   Dunbar, Rod ^c   Cerundolo, Vincenzo ^c   Lejeune, Ferdy ^a   Cerottini, Jean Charles ^a,b   Romero, Pedro ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA A2 ANTIGEN; MELANOMA ANTIGEN; TETRAMER;

ADOPTIVE TRANSFER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SELECTION; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; PROTEIN TARGETING; SUPPRESSOR CELL;

ANTIGENS, NEOPLASM; BIOTINYLATION; CELL LINE; CELL SEPARATION; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HLA-A2 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MACROMOLECULAR SUBSTANCES; MELANOMA; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0033135052     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Romero, P. Cylolytic T lymphocyte responses of cancer patients to tumor-associated antigens. Springer Semin. Immunopathol., 18: 185-198, 1996.
2. Robbins, P. F., and Kawakami, Y. Human tumor antigens recognized by T cells. Curr. Opin. Immunol., 8: 628-636, 1996.
3. Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A. C., Melden, R. H., van der Eb, A. J., and Melief, C. J. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell, 59: 603-614, 1989.
4. Rosenberg, S. A., Spiess, P., and Lafreniere, R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science (Washington DC), 233: 1318-1321, 1986.
5. Melief, C. J. M. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res., 58: 143-175, 1992.
6. Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., de Jongh, B. M., Drijfhout, J. W., ter Schegget, J., Melief, C. J. M., and Kast, W. M. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol., 23: 2242-2249, 1993.
7. Melief, C. J. M., and Martin Kast, W. T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes. Immunol. Rev., 146: 167-177, 1995.
8. Rosenberg, S. A., Packard, B. S., Aebersold, P. M., Solomon, D., Topalian, S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., Simpson, C., Carter, C., Bock, S., Schwartzentruber, D., Wei, J. P., and White, D. E. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N. Engl. J. Med., 319: 1676-1680, 1988.
9. Topalian, S. L., Solomon, D., Avis, F. P., Chang, A. E., Freerksen, D. L., Linehan, W. M., Lotze, M. T., Robertson, C. N., Seipp, C. A., and Simon, P. Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J. Clin. Oncol., 6: 839-853, 1988.
10. Romero, P., Dunbar, P. R., Valmori, D., Pittet, M., Ogg, O. S., Rimoldi, D., Chen, J. L., Liénard, D., Cerottini, J. C., and Cerundolo, V. Ex vivo staining of metastatic lymph nodes by class I MHC tetramers reveals high numbers of antigen-experienced tumor specific CTL. J. Exp. Med., 188: 1641-1650, 1998.
11. Valmori, D., Fonteneau, J. F., Marañón Lizana, C., Gervois, N., Liénard, D., Rimoldi, D., Jongeneel, C. V., Jotereau, F., Cerottini, J. C., and Romero, P. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogs. J. Immunol., 160: 1750-1758, 1998.
12. Jungbluth, A. A., Busam, K. J., Gerald, W. L., Stockert, E., Coplan, K. A., Iversen, K., MacGregor, D. P., Old, L. J., and Chen, Y. T. A103: an anti-Melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am. J. Surg. Pathol., 22: 595-602, 1998.
13. Ljunggren, H-G., Stam, N. J., Ohlen, C., Neefjes, I. J., Höglund, P., Heemels, M. T., Bastin, J., Schumacher, T. N. M., Townsend, A., Karre, K., and Ploegh, H. L. Empty MHC class I molecules come out in the cold. Nature (Lond.), 346: 476-480, 1990.
14. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., McMichael, A. J., Bell, J. I., and Davis, M. M. Phenotypic analysis of antigen-specific T lymphocytes. Science (Washington DC), 274: 94-96, 1996.
15. Koniaras, C., Heath, W. R., and Lew, A. M. T-cell unresponsiveness in vitro can be due to activation in vivo. Int. Immunol., 10: 365-369, 1998.
16. Valmori, D., Gervois, N., Rimoldi, D., Fonteneau, J. F., Bonelo, A., Liénard, D., Rivoltini, L., Jotereau, F., Cerottini, J-C., and Romero, P. Diversity of the fine specificity displayed by HLA-A*0201 -restricted CTL specific for the immundominant Melan-A/MART-1 antigenic peptide. J. Immunol., 161: 6956-6962, 1998.
17. Rosenberg, S. A., Yannelli, J. R., Topalian, S. L., Schwartzentruber, D. J., Weber, J. S., Parkinson, D. R., Seipp, C. A., Einhorn, J. H., and White, D. E. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J. Natl. Cancer Inst., 86: 1159-1165, 1994.
18. Fisher, B., Packard, B. S., Read, E. J., Carrasquillo, J. A., Carter, C. S., Topalian, S. L., Yang, J. C., Yolles, P., Larson, S. M., and Rosenberg, S. A. Tumor localization of adoptively transferred indium-Ill labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J. Clin. Oncol., 7: 250-261, 1989.
19. Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., and Rosenberg, S. A. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol., 154: 3961-3968, 1995.
20. D'Souza, S., Rimoldi, D., Liénard, D., Lejeune, F., Cerottini, J. C., and Romero, P. Circulating Melan-A/M ART-1 specific cytolytic T lymphocyte precursors in HLA-A2* melanoma patients have a memory phenotype. Int. J. Cancer, 78: 699-706, 1998.
21. Parkhurst, M. R., Salgaller, M. L., Southwood, S., Robbins, P. F., Sette, A., Rosenberg, S. A., and Kawakami, Y. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified HLA-A*0201 -binding residues. J. lmmunol., 157: 2539-2548, 1996.
22. Bakker, A. B. H., van der Burg, S. H., Huijbens, R. J. F., Drijfhout, J. W., Melief, C. J. M., Adema, G. J., and Figdor, C. G. Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope. Int. J. Cancer, 70: 302-309, 1997.
23. Greenberg, P. D., Kern, D. E., and Cheever, M. A. Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+, 2- T cells. Tumor eradication does not require participation of cytotoxic T cells. J. Exp. Med., 161: 1122-1134, 1985.
24. Greenberg, P. D. Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolylic T cells can mediate eradication of disseminated leukemia. J. Immunol., 136: 1917-1922, 1986.
25. Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., and Riddell, S. R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med., 333: 1038-1044, 1995.
26. + T lymphocytes against human melanoma: evidence for a shared melanoma antigen presented by HLA-DR15. J. Immunol., 154, 772-779, 1995.
27. Maccalli, C., Mortarini, R., Parmiani, G., and Anichini, A. Multiple subsets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles. Int. J. Cancer, 57, 56-62, 1994.
28. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA, 91: 9461-9465, 1994.
29. + T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus. J. Immunol., 157: 4079-4086, 1996.
30. Crawford, F., Kozono, H., White, J., Marrack, P., and Kappler, J. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity, 8: 675-682, 1998.
31. Gulgemann, I., Fahrer, A. M., Altman, J. D., Davis, M. M., and Chien, Y. H. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity, 8: 667-673, 1998.
32. Nagoya, S., Greenberg, P. D., Yee, C., Weisser, K. E., Sugawara, H., Widmer, M. B., Slack, J., Dower, S. K., Lupton, S. D., and Overell, R. W. Helper T cell-independent proliferation of CD8+ cytotoxic T lymphocytes transduced with an IL-1 receptor retrovirus. J. Immunol., 153: 1527-1535, 1994.
33. Nelson, B. H., Lord, J. D., and Greenberg, P. D. Cytoplasmic domains of the IL-2 receptor β and γ chains mediate the signal for T-cell proliferation. Nature (Lond.), 369: 333-336, 1994.